Citation Impact
Citing Papers
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2015
A Variant of Lymphomatoid Papulosis Simulating Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma. Description of 9 Cases
2010
Psoriasis
2021 Standout
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Skin penetration enhancers
2013 Standout
Psoriasis
2015 Standout
Obesity in autoimmune diseases: Not a passive bystander
2014
Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study
2013
Strong irritants masquerading as skin allergens: the case of benzalkonium chloride
2004
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Works of R. Rivera being referenced
Allergic contact dermatitis from benzalkonium chloride used as a denaturant of ethanol
1996
Riesgo de reactivación de hepatitis B pasada en pacientes con psoriasis tratados con biológicos. Análisis retrospectivo de 20 casos. Registro de BIOBADADERM
2015
Position statement for the management of comorbidities in psoriasis
2018
Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry
2013
Hígado graso no alcohólico y psoriasis
2010
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database
2015
Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with atypical cells
2003
Nonalcoholic Fatty Liver Disease and Psoriasis
2010
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis
2016
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
2015